Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Active substance : paclitaxel
  • Topics : Breast cancers
Filter
Topic
  • Diagnostic and therapeutic techniques (2)
  • Plus ...
    • Drug therapy (1)
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
      • Cell and tissue pathology (1)
  • Diseases and conditions (2)
  • Plus ...
    • Breast diseases (2)
    • Plus ...
      • Breast cancers (2)
    • Respiratory tract diseases (1)
    • Plus ...
      • Respiratory tract cancers (1)
    • Digestive system diseases (1)
    • Plus ...
      • Digestive system cancers (1)
    • Endocrine system and metabolic diseases (1)
    • Plus ...
      • Endocrine gland cancers (1)
Content type
  • Drugs, devices and medical acts (2)
  • Plus ...
    • Medicine (1)
    • Health technology assessment (1)
Date
  • Last five years (1)
Fabricant
  • industriels (1)
Langue
  • Français (2)
Substance active
  • cyclophosphamide (1)
  • paclitaxel (2)
More filter Other Filter Icon
Search Export

Drugs, devices and medical acts - 2 results

  • 2023 update: clinical utility of genomic signatures in early-stage HR-positive/HER2-negative breast cancer - InaHTA Brief

    Health technology assessment - Posted on 22/11/2023
    Download document
    Add to my selection

  • ABRAXANE (paclitaxel)

    Medicine - Posted on 30/9/2016 - Mis à jour le 12/6/2019
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
6tvYFVw7DcG50g7e